CSIMarket
 
Sera Prognostics Inc   (SERA)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $9.2600 $0.32 3.579%
Day's High: $9.3 Week Perf: 0.33 %
Day's Low: $ 8.77 30 Day Perf: 3.23 %
Volume (M): 146 52 Wk High: $ 10.44
Volume (M$): $ 1,355 52 Wk Avg: $3.94
Open: $8.89 52 Wk Low: $1.52



 Market Capitalization (Millions $) 290
 Shares Outstanding (Millions) 31
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -38
 Cash Flow (TTM) (Millions $) -49
 Capital Exp. (TTM) (Millions $) 1

Sera Prognostics Inc
Sera Prognostics Inc is a biotechnology company that specializes in developing diagnostic tests for predicting the risk of preterm birth and other pregnancy-related complications. The company utilizes advanced proteomic technologies to analyze protein biomarkers found in maternal blood samples. By measuring these biomarkers, Sera Prognostics aims to provide healthcare professionals with valuable information to guide personalized medical interventions and improve the outcomes of high-risk pregnancies. Their main product is the PreTRM test, which is designed to assess the risk of preterm delivery up to 12 weeks before symptoms occur. Sera Prognostics is dedicated to advancing the field of women's health and reducing the incidence of preterm birth through their innovative diagnostic solutions.


   Company Address: 2749 East Parleys Way Salt Lake City 84109 UT
   Company Phone Number: 990-0520   Stock Exchange / Ticker: NASDAQ SERA
   SERA is expected to report next financial results on March 21, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Sera Prognostics Inc

Revitalizing Growth: Sera Prognostics Inc Breaks Free from Diminishing Returns



Sera Prognostics Inc, a leading player in the Medical Laboratories industry, recently released its financial results for the July to September 2023 period. Despite witnessing a decline in revenue, the company managed to reduce its loss per share, showcasing its ability to improve its financial position. Let's examine these results in the context of the stock performance and industry trends.
Improved Loss per Share:
During the reported period, Sera Prognostics Inc recorded a loss per share of $-0.23, which marks a significant improvement compared to the loss of $-0.35 per share reported in the same period a year ago. This positive development indicates that the company has made progress towards profitability and is effectively managing its expenses.

Sera Prognostics Inc

Sera Prognostics Inc Reports Significant Loss of $-0.34 per Share in Latest Fiscal Period, Raises Concerns Over Company's Financial Performance

In the most recent fiscal period, Sera Prognostics Inc experienced a loss of $0.34 per share, an improvement from the previous year's loss of $0.37 per share and matching the loss from the previous reporting season. Although the company's earnings are still in negative territory, this trend towards lower losses is a positive sign for investors.
On the revenue front, Sera Prognostics Inc saw a significant increase of 57.692% to $0.12 million from the same period the previous year. Sequentially, the company's revenue grew by 23% from $0.10 million. This growth in revenue is quite impressive, especially when compared to its peers in the Medical Laboratories sector, as most companies in this industry reported an average revenue growth of only 3.66% in the second quarter of 2023 compared to the same period in the previous year.






 

Sera Prognostics Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com